Literature DB >> 2838522

Phenotypic conversion of T lymphoblastic lymphoma to acute biphenotypic leukemia composed of lymphoblasts and myeloblasts. Molecular genetic evidence of the same clonal origin.

T Nosaka1, H Ohno, S Doi, S Fukuhara, H Miwa, K Kita, S Shirakawa, T Honjo, M Hatanaka.   

Abstract

Acute biphenotypic leukemia composed of lymphoblasts and myeloblasts developed in a patient with T lymphoblastic lymphoma (T-LBL) who had an anterior mediastinal mass. A novel myeloid cell line, termed TK-1, has been established from his peripheral blood after the leukemic conversion. The identical rearranged pattern of T cell receptor gamma-chain gene was observed among the DNAs derived from lymph node cells in the lymphoma phase, the myeloid cell line TK-1, and the subclones with different karyotypes (TK-1B and TK-1D), which showed that myeloid cells had been derived from the T-LBL of the same patient. This finding demonstrates that phenotypic conversion occurs in the clonally propagating tumor cells and suggests that some hematopoietic cells retain the capacity to adopt either lineage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838522      PMCID: PMC442631          DOI: 10.1172/JCI113526

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  Renewal and commitment to differentiation of hemopoietic stem cells (an interpretive review).

Authors:  M Ogawa; P N Porter; T Nakahata
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

2.  Phenotypic conversion of acute leukaemia from T-lymphoblastic to myeloblastic induced by therapy with 2'-deoxycoformycin.

Authors:  S B Murphy; S Stass; D Kalwinsky; G Rivera
Journal:  Br J Haematol       Date:  1983-10       Impact factor: 6.998

3.  Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.

Authors:  M S Hershfield; J Kurtzberg; E Harden; J O Moore; J Whang-Peng; B F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Cloning of human immunoglobulin mu gene and comparison with mouse mu gene.

Authors:  N Takahashi; S Nakai; T Honjo
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

5.  T-cell lymphoblastic lymphoma with subsequent acute nonlymphocytic leukemia: a case report.

Authors:  M R Posner; J Said; G S Pinkus; L M Nadler; R Hardy; F Flatow; A T Skarin
Journal:  Cancer       Date:  1982-07-01       Impact factor: 6.860

6.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

Review 7.  Acute myeloblastic leukemia developing in patients with mediastinal lymphoblastic lymphoma.

Authors:  C R Kjeldsberg; B N Nathwani; H Rappaport
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

8.  Biphenotypic leukemia: immunologic and morphologic evidence for a common lymphoid-myeloid progenitor in humans.

Authors:  J Perentesis; N K Ramsay; R Brunning; J H Kersey; A H Filipovich
Journal:  J Pediatr       Date:  1983-01       Impact factor: 4.406

9.  Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.

Authors:  S J Korsmeyer; P A Hieter; J V Ravetch; D G Poplack; T A Waldmann; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

Review 10.  Second neoplasms in acute lymphoblastic leukemia.

Authors:  M H Zarrabi; F Rosner; H W Grünwald
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

View more
  4 in total

Review 1.  A classification of acute leukaemia for the 1990s.

Authors:  D Catovsky; E Matutes; V Buccheri; V Shetty; J Hanslip; N Yoshida; R Morilla
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors.

Authors:  Yoshihiro Baba; Karla P Garrett; Paul W Kincade
Journal:  Immunity       Date:  2005-12       Impact factor: 31.745

3.  Successful reduced-intensity stem cell transplantation from an HLA haploidentical 3-loci-mismatched donor on the basis of fetomaternal microchimerism in a patient with advanced acute myeloid leukemia.

Authors:  Nobuhiko Uoshima; Yuri Kamitsuji; Etsuko Maruya; Hiroh Saji
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

4.  Mature T-lineage leukemia with growth factor-induced multilineage differentiation.

Authors:  F Griesinger; D C Arthur; R Brunning; J L Parkin; A C Ochoa; W J Miller; C W Wilkowski; J M Greenberg; C Hurvitz; J H Kersey
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.